A Randomized, Double-blind, Placebo-controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Intravenous AOC 1020 for the Treatment of Facioscapulohume…

Facioscapulohumeral Muscular DystrophyFSHDFSHD - Facioscapulohumeral Muscular Dystrophy+14 more

~Estimated

~$10 – $8,750

Avidity Biosciences, Inc.NCT07038200

Phase 1

A Phase 1, Double-blinded, Randomized, Dose-repeating, Placebo-controlled, Cross-over Study to Assess the Safety and Preliminary Efficacy of Allogeneic ULSC on Disease Severity in Facioscapulohumeral Muscular Dystrophy (FSHD)

The goal of this clinical trial is to learn about how an umbilical cord lining-derived stem cell product (ULSC) performs when treating Facioscapulohumeral Musc…

FSHD - Facioscapulohumeral Muscular Dystrophy

~Estimated

~$10 – $8,750

Restem, LLC.NCT07086521

BetterLife FSHD: A Patient-driven Health and Research Platform

BetterLife FSHD is a registry platform built to support people living with FSHD. It connects patients with personalized resources, tools, and research opportun…

FSHFSH Muscular DystrophyFSHD - Facioscapulohumeral Muscular Dystrophy+8 more

~Estimated

~$10 – $1,125

FSHD SocietyNCT07409142